Wharton’s jelly-derived mesenchymal stromal cells
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Wharton’s jelly-derived mesenchymal stromal cells, covering 2023-04-03 to 2025-03-07. Get the full timeline:
Most recent: Clinical Trial Update: Wharton´s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed with Type I Diabetes [Phase 1, Phase 2]